Medical News

RSS

ETI finalizes proprietary progesterone formulations for Traumatic Brain Injury

Encore Therapeutics, Inc. today reported finalizing its proprietary phospholipid nanoemulsion formulation of progesterone.

12 May 2011

Chemical engineer builds working models of human tissues for disease research

Shelly Peyton, a chemical engineer at the University of Massachusetts Amherst, is building working models of human bone, breast, liver and artery tissues to see how cells behave when they are affected by a disease such as cancer.

12 May 2011

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

Doctors in Germany are among the first to treat ischemic stroke patients outside the United States with the REVIVE SE, a new self-expanding blood clot retrieval and removal device designed to remove blood clots and restore blood flow to the brain in patients having a stroke.

12 May 2011

InTouch Health applauds FDA for recent announcement on Medical Device Data Systems

In response to the recent announcement issued by the Food and Drug Administration regarding Medical Device Data Systems, InTouch Health affirms its position of compliance, and applauds the agency for issuing regulations governing the use of hardware and software in the healthcare information technology space.

12 May 2011

Medtronic to present new clinical results on innovative medical devices at EuroPCR

New clinical data on a range of innovative medical devices from Medtronic, Inc., to treat cardiac and vascular diseases - from severe aortic stenosis and uncontrolled hypertension, to coronary and peripheral artery disease - will be presented next week at EuroPCR. Many of the presentations will be featured during late-breaking sessions at this large international interventional cardiology meeting, which takes place in Paris from May 17-20.

From Medtronic 12 May 2011

Bovie Medical first quarter revenues increase 10% to $6.2 million

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter and year ended March 31, 2011.

12 May 2011

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Trillium Therapeutics Inc., a privately-held biopharmaceutical company, announced today that it has raised $1 million from a new undisclosed investor. The funds will be used to advance its lead program, TTI-1612, into clinical trials for the treatment of interstitial cystitis, also known as bladder pain syndrome. The first trial is projected to start in the second half of this year.

12 May 2011

Cipher first quarter net revenue decreases to $0.7 million

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three months ended March 31, 2011.

12 May 2011

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, presented new clinical and pre-clinical data related to the safety and efficacy of its novel, lead defensin-mimetic antibiotic, PMX-30063.

12 May 2011

Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies

Linguamatics, the leader in NLP-based enterprise text mining for life sciences and other markets, announces the latest release of its award-winning software platform, I2E.

12 May 2011

Aradigm first quarter total revenue decreases to $0.2 million

Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2011.

12 May 2011

New organocatalyst now available for drug development industry

A new "organocatalyst" developed at Oregon State University is now available for commercial use. Produced by an Albany, Ore., pharmaceutical company, it should make new drug development around the world less costly, more efficient and more environmentally friendly.

12 May 2011

Children can benefit from The Asthma Management Plans in School Act

New legislation introduced by Rep. Mazie Hirono (D-HI) would provide grants for asthma management programs in schools across the U.S. in a step to ensure the nation's 7.1 million children with asthma have access to care that could save their lives.

12 May 2011

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

As one of the first medical centers in the Northwest to perform robotic-assisted surgery, Swedish is home to the fastest growing, most comprehensive and experienced robotic-assisted surgical program in the region. Swedish established the multidisciplinary, robotic-assisted surgical program in 2005 and has since performed more than 3,400 robotic-assisted surgeries -- more than any other program in the region.

12 May 2011

Biocept's paper describes identification of different CTC phenotypes in cancer patients

Biocept, Inc., a privately-held laboratory testing company focused on the detection, enumeration and analysis of circulating tumor cells (CTCs) in cancer patients, today announced the publication of a paper describing the identification of different CTC phenotypes using its proprietary Cell Enrichment and Extraction platform.

12 May 2011

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

Miltenyi Biotec, the only company to offer a seamless experimental integration path from sample preparation through cell separation, culture, and analysis for primary cells, today entered into a strategic alliance with TeutoCell, a provider of cutting edge cell culture technology.

12 May 2011

Prestige Brands fourth fiscal quarter revenue increases 37.8% to $96.4 million

Prestige Brands Holdings, Inc. today announced results for the fourth fiscal quarter and full year ended March 31, 2011.

12 May 2011

Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting

Today Merck announced that Health Canada has approved the new intravenous formulation of EMEND IV. Used in combination with a 5-HT3 antagonist class of antiemetics and dexamethasone, fosaprepitant dimeglumine is indicated for the prevention of acute and delayed nausea and vomiting due to highly emetogenic cancer chemotherapy.

12 May 2011

Kool Smiles inaugurates new San Angelo dental office

Kool Smiles, a leading dental health provider for children and adults, now has opened its doors to additional families in Texas with a new office location in San Angelo. Kool Smiles of San Angelo officially opened on February 7 as the organization continues to expand access to quality dental care for families in underserved communities across the nation.

12 May 2011

Cell Biosciences announces acquisition of Brightwell Technologies

Cell Biosciences, Inc. today announced that it has acquired Brightwell Technologies, Inc. of Ottawa, Ontario for approximately U.S. $9 million in cash.

12 May 2011

Medical News

ETI finalizes proprietary progesterone formulations for Traumatic Brain Injury

Chemical engineer builds working models of human tissues for disease research

German doctors among first to treat ischemic stroke patients with new blood clot retrieval device

InTouch Health applauds FDA for recent announcement on Medical Device Data Systems

Medtronic to present new clinical results on innovative medical devices at EuroPCR

Bovie Medical first quarter revenues increase 10% to $6.2 million

Trillium raises $1 million to advance TTI-1612 into clinical trials for interstitial cystitis treatment

Cipher first quarter net revenue decreases to $0.7 million

New clinical data affirms safety profile of PolyMedix's PMX-30063 in treatment of Staph infections

Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies

Aradigm first quarter total revenue decreases to $0.2 million

New organocatalyst now available for drug development industry

Children can benefit from The Asthma Management Plans in School Act

Swedish adds new virtual reality training simulator to help surgeons practice on robotic-assisted system

Biocept's paper describes identification of different CTC phenotypes in cancer patients

Miltenyi Biotec enters partnership with TeutoCell to develop novel cell culture techniques

Prestige Brands fourth fiscal quarter revenue increases 37.8% to $96.4 million

Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting

Kool Smiles inaugurates new San Angelo dental office

Cell Biosciences announces acquisition of Brightwell Technologies

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News